Quality of life in a community sample of young cocaine and/or heroin users: the role of mental disorders


Por: Chahua, M, Sanchez-Niubo, A, Torrens, M, Sordo, L, Bravo, MJ, Brugal, MT, Domingo-Salvany, A

Publicada: 1 sep 2015
Resumen:
Purpose Drug addiction and psychiatric disorders are frequently concomitant; however, few studies have investigated the impact of psychiatric disorders other than substance use disorder (SUD) on health-related quality of life (HRQoL) in drug users not in treatment. We studied the association of psychiatric disorders other than SUD with HRQoL in a street-recruited sample of cocaine and/or heroin users. Methods It is a cross-sectional study involving 287 young users of cocaine and/ or heroin in Barcelona, Spain. HRQoL was assessed with the Nottingham health profile (NHP). Patterns of drug use and mental disorders were assessed using the Spanish version of the psychiatric research interview for substance and mental disorders IV, and degree of dependence through the severity of dependence scale (SDS). The association of mental disorders with HRQoL was assessed through a Tobit regression analysis. Results The overall NHP score was 23.9 (SD = 20.5, range 0-91.7). Sixty-one percent of the sample had two or more SUDs; 22 % had at least one non-SUD Axis I disorder (anxiety, mood, psychotic, or eating disorder); and 27.2 % had a borderline personality disorder (BPD) and/or antisocial personality disorder. Variables negatively associated with the global NHP score were psychosis [transformed beta coefficient: 15.23; 95 % confidence interval [CI] 4.48-25.97], BPD (9.55; 95 % CI 2.95-16.15), severity of dependence (8.12; 95 % CI 3.37-12.87), having two or more SUDs (for two or three SUDs: 6.83; 95 % CI 2.08-11.59) (>3 SUDs: 7.70; 95 % CI 1.72-13.68) and the intravenous use of some substance (10.20; 95 % CI 6.00-14.40). Conclusion HRQoL among street-recruited illegal substance users was impaired, particularly among those with psychiatric comorbidity, psychosis, and BPD being especially relevant.

Filiaciones:
Chahua, M:
 Inst Salud Carlos III, Escuela Nacl Sanidad, Madrid, Spain

Sanchez-Niubo, A:
 IMIM, Hosp del Mar, Drug Abuse Epidemiol Res Grp, Barcelona 08002, Spain

Torrens, M:
 IMIM, Hosp del Mar, Addict Res Grp, Barcelona 08002, Spain

 Univ Autonoma Barcelona, Dept Psychiat, Catalonia, Spain

Sordo, L:
 Inst Salud Carlos III, Ctr Nacl Epidemiol, Madrid, Spain

 Univ Complutense Madrid, Fac Med, Dept Med Prevent & Salud Publ, Madrid, Spain

 CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain

Bravo, MJ:
 Inst Salud Carlos III, Ctr Nacl Epidemiol, Madrid, Spain

 CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain

Brugal, MT:
 Agencia Salut Publ Barcelona, Barcelona, Spain

 Inst Invest Biomed IIB St Pau, Barcelona, Spain

Domingo-Salvany, A:
 IMIM, Hosp del Mar, Drug Abuse Epidemiol Res Grp, Barcelona 08002, Spain
ISSN: 09629343
Editorial
SPRINGER, VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS, Países Bajos
Tipo de documento: Article
Volumen: 24 Número: 9
Páginas: 2129-2137
WOS Id: 000361010800008
ID de PubMed: 25682367
imagen Green Accepted

MÉTRICAS